S-cubed Pharmaceutical Services ApS: Financial statements 2025
CVR: 39035448
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
S-cubed Pharmaceutical Services ApS (CVR 39035448) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK 1,235 and a net result of DKK -959 compared with DKK -51,181 the year before. Equity in the 2025 report amounted to DKK 599,313. The solvency ratio was 98.7%.
- Gross Profit
- DKK 1,235
- Profit/Loss
- DKK -959
- Equity
- DKK 599,313
- Total Assets
- DKK 607,313
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | 1K | -959 | 599K | 0 |
| 2024 | - | -49K | -51K | 600K | - |
| 2023 | - | 4K | 4K | 651K | - |
| 2022 | - | 237K | 175K | 647K | - |
| 2021 | - | 397K | 323K | 473K | 1 |
Official annual report
How creditworthy is S-cubed Pharmaceutical Services ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
S-cubed Pharmaceutical Services ApS has published its annual report for 2024. Gross profit came to DKK -49,426, and the net result was DKK -51,181.
About S-cubed Pharmaceutical Services ApS
S-cubed Pharmaceutical Services ApS is a Danish company of the type Anpartsselskab based in Frederikssund, founded in 2017. The company is registered under the industry Anden teknisk rådgivning. The management consists of Mark Dennis Lipscombe. The company is owned by S-Cubed Limited. The company has 1 employee (2018). In 2025, the company reported a gross profit of DKK 1,235 and a net result of DKK -959 compared with DKK -51,181 the year before. Equity in the 2025 report amounted to DKK 599,313.